Hh and AXL pathways are known to play an important role in EGFR resistance [6, 22, 37] through EMT; in one resistant tumor we found that Hh and AXL are concomitantly strongly activated, suggesting that further studies are needed to investigate the interplay between different resistance signaling. Here, AXL is linked to neoplasm.